News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

Paul Harber, Modality Solutions

Advertisement

Articles by Paul Harber, Modality Solutions

A new way to look at the performance of passive cold-chain shipping containers

ByBernard McGarvey, Eli Lilly,Co.,Geoff Kaiser and Shreyas Panse, Cold Chain Technologies,Paul Harber, Modality Solutions
February 2nd 2016

A 'performance curve' chart for containers could simplify the design process

Advertisement

Latest Updated Articles

  • A new way to look at the performance of passive cold-chain shipping containers
    A new way to look at the performance of passive cold-chain shipping containers

    Published: February 2nd 2016 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

Novo Nordisk’s Bloomington Plant Receives FDA OAI Designation Following Contamination and Compliance Issues

2

Why Regulatory Sandboxes Offer a Safe Space for AI Innovation in Healthcare

3

Pharma Pulse: Kaiser Permanente Strike Escalates, Takeda Partners with Nabla Bio, and FDA Flags Novo Nordisk Bloomington Site

4

Pharma Pulse: CDC Layoffs Raise Public Health Concerns as Ypsomed and Lupin Expand US Manufacturing Footprint

5

Lupin Invests $250 Million in New Coral Springs Manufacturing Facility to Bolster US Respiratory Drug Supply

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us